US Biomedical Leadership Threatened by NIH Licensing Guidelines

Truth on the Market

Factuality

Ownership

US Biomedical Leadership Threatened by NIH Licensing Guidelines

New licensing guidelines issued by the National Institutes of Health (NIH) at the end of the Biden administration could undermine American innovation in the biomedical field—a sector in which the United States has long been the world leader. In a period of growing international competition, including threats from China, the Trump administration may want to closely examine and consider rescinding the new NIH guidelines. Background: The Bayh-Dole …